D.9. Key Learning Outcomes

1. Has enough knowledge and skill level on determination of pharmacokinetic data that originate from bioavailability parameters.

2. Knows on the in vitro and in vivo evaluation of modern therapeutic systems, controlled release and targeted systems, and biotechnology products

3. Can evaluate how the availability of pharmaceutical dosage forms are affected by preformulation and formulation design and perform practical application in laboratory conditions

4. Can evaluate statistical and mathematical capability for the evaluation of drug effectiveness.

5. By using computer softwares, has enough knowledge on how the active ingredient release is affected by formulation design.

6. Follows the most updated literature, evaluates the knowledge and learns how to make scientific research in the light of these knowledge, reports the data that they handle. Learns how to use the necessary instruments and their technical information.

7. For the problems that they face; they will have the ability to solve the problem in the light of literature data; in addition they will gain the ability to solve the problem depending on the knowledge of different sources.

8. They may integrate into multidisciplinary studies, may perform own duties in a scientific project.

9. Has knowledge on in vitro/in vivo correlation, may evaluate the topic with necessary mathematical and statistical methods. 10. They will have the capability to make comments on GMP, GLP, GCP, NDA, ANDA, BA/BE, QA/QC on their topics.

10. They will have the capability to make comments on GMP, GLP, GCP, NDA, ANDA, BA/BE, QA/QC on their topics.

11. Knows how to prepare files for animal experiments and studies on healthy and sick volunteers by the Declaration of Helsinki.